Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julius Schachter

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Sexually Transmitted Diseases|May 8, 2007
The Chlamydia trachomatis plasmid deletion mutant--what does it mean to us?Julius Schachter
Expert Review of Molecular Diagnostics|October 19, 2013
Will droplet digital PCR become the test of choice for detecting and quantifying ocular Chlamydia trachomatis infection? Maybe notJulius Schachter
Sexually Transmitted Infections|February 21, 2016
Point-of-care tests using enzyme detection to diagnose Chlamydia trachomatis infection do not work. But when they fail in clinical trials, they reappear under different namesJulius Schachter
The New England Journal of Medicine|May 5, 2016
Azithromycin versus Doxycycline for ChlamydiaJulius Schachter
Sexually Transmitted Diseases|March 15, 2013
A letter to members of the American Sexually Transmitted Diseases Association on Thomas Parran and the Guatemalan Sexually Transmitted Disease Studies: What did he know? What did he do? What do we do?Julius Schachter
Journal of Clinical Microbiology|May 31, 2019
Alternate Nucleic Acid Targets Can Be Used To Create a Composite Standard To Evaluate Clinical Performance of Nucleic Acid Amplification TestsJulius Schachter, Max Chernesky
Sexually Transmitted Diseases|May 25, 2005
Lymphogranuloma venereum: how to turn an endemic disease into an outbreak of a new disease? Start lookingJulius Schachter, Jeanne Moncada
Current Opinion in Infectious Diseases|April 11, 2003
Elimination of blinding trachomaJulius Schachter, Chandler R Dawson
Lancet (London, England)|January 29, 2002
Should trachoma be treated with antibiotics?Chandler R Dawson, Julius Schachter
The Journal of Infectious Diseases|December 28, 2006
Prototype misidentification makes conclusions about pathotype growth characteristics uncertainJulius Schachter, Chandler R Dawson
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Sexually Transmitted Diseases|May 8, 2007
The Chlamydia trachomatis plasmid deletion mutant--what does it mean to us?Julius Schachter
Expert Review of Molecular Diagnostics|October 19, 2013
Will droplet digital PCR become the test of choice for detecting and quantifying ocular Chlamydia trachomatis infection? Maybe notJulius Schachter
Sexually Transmitted Infections|February 21, 2016
Point-of-care tests using enzyme detection to diagnose Chlamydia trachomatis infection do not work. But when they fail in clinical trials, they reappear under different namesJulius Schachter
The New England Journal of Medicine|May 5, 2016
Azithromycin versus Doxycycline for ChlamydiaJulius Schachter
Sexually Transmitted Diseases|March 15, 2013
A letter to members of the American Sexually Transmitted Diseases Association on Thomas Parran and the Guatemalan Sexually Transmitted Disease Studies: What did he know? What did he do? What do we do?Julius Schachter
Journal of Clinical Microbiology|May 31, 2019
Alternate Nucleic Acid Targets Can Be Used To Create a Composite Standard To Evaluate Clinical Performance of Nucleic Acid Amplification TestsJulius Schachter, Max Chernesky
Sexually Transmitted Diseases|May 25, 2005
Lymphogranuloma venereum: how to turn an endemic disease into an outbreak of a new disease? Start lookingJulius Schachter, Jeanne Moncada
Current Opinion in Infectious Diseases|April 11, 2003
Elimination of blinding trachomaJulius Schachter, Chandler R Dawson
Lancet (London, England)|January 29, 2002
Should trachoma be treated with antibiotics?Chandler R Dawson, Julius Schachter
The Journal of Infectious Diseases|December 28, 2006
Prototype misidentification makes conclusions about pathotype growth characteristics uncertainJulius Schachter, Chandler R Dawson
Pageof 7